Aurobindo Pharma
-
Aurobindo Pharma arm's New Jersey unit gets warning letter from USFDA
India | Oct 22, 2020, 11:05 AM ISTDrug firm Aurobindo Pharma Thursday said its step-down subsidiary has received a warning letter from the US health regulator for its unit in New Jersey, US.
-
Aurobindo Pharma shares up 17% as USFDA grants VAI classification for Hyderabad unit
Business | Apr 21, 2020, 12:57 PM ISTAurobindo Pharma on Tuesday said the US health regulator has decided that the inspection classification of company's injectable formulation manufacturing facility at Hyderabad is voluntary action indicated (VAI).
-
USFDA revokes action against Aurobindo Pharma's Hyderabad unit
Business | Feb 21, 2020, 07:14 PM ISTDrug firm Aurobindo Pharma on Friday said the US health regulator has revoked the voluntary action initiated (VAI) status for its Unit-IV facility in Hyderabad.
-
Aurobindo Pharma to acquire US company Natrol for Rs 810 cr
Nov 12, 2014, 03:32 PM ISTNew Delhi: Aurobindo Pharma is all set to acquire troubled US-based nutritional supplement maker, Natrol Inc for USD 132.5 million (over Rs 810 crore) after emerging as the highest bidder for acquisition.Aurobindo Pharma USA Inc,
-
Aurobindo Pharma Jul-Sep quarter net up 58% to Rs 372 cr
Nov 07, 2014, 02:25 PM ISTNew Delhi: Aurobindo Pharma today reported 58.3 per cent jump in consolidated net profit at Rs 372.2 crore for the quarter ended September on the back of robust growth in the US market.The company had
-
MSCI adds Aurobindo Pharma to India index
May 15, 2014, 02:30 PM ISTNew Delhi: The MSCI Global Standard Indices will see the addition of Aurobindo Pharma with effect from May 30.The change will take place as on close of May 30, MSCI had said on Wednesday. Shares of
-
Aurobindo Pharma gets USFDA nod for HIV infection tablets
Jun 28, 2013, 03:49 PM ISTNew Delhi, June 28: Drug firm Aurobindo Pharma has said it has received tentative approval from the US health regulator to manufacture and market efavirenz, lamivudine and tenofovir disoproxil fumarate tablets used for treating a
-
Aurobindo Pharma gets USFDA nod for anti-hypertension drug
Apr 30, 2013, 02:11 PM ISTNew Delhi, April 30:Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Quinapril tablets. The tablet is generic equivalent of Pfizer Pharmaceuticals Ltd's Accupril tablets and